WO1999049068A1 - Process for producing 1-substituted-3-methoxy-4-oxybenzenes - Google Patents
Process for producing 1-substituted-3-methoxy-4-oxybenzenes Download PDFInfo
- Publication number
- WO1999049068A1 WO1999049068A1 PCT/JP1999/001493 JP9901493W WO9949068A1 WO 1999049068 A1 WO1999049068 A1 WO 1999049068A1 JP 9901493 W JP9901493 W JP 9901493W WO 9949068 A1 WO9949068 A1 WO 9949068A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methoxy
- substituted
- producing
- clove oil
- oxybenzenes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
Definitions
- the present invention is expected to be widely used as a raw material for pharmaceuticals, cosmetics, agricultural chemicals, food additives, feed additives, liquid crystals, etc. 1—
- the present invention relates to a process for producing substituted 3-methoxy-4-oxybenzenes.
- Monosubstituted 1-3-methoxy-4-methoxybenzenes such as ferulic acid, vanillin, and vanillic acid, are naturally occurring and can be obtained by extraction from natural products, but the amount of natural products The extraction process is cumbersome and expensive, and is not suitable for mass production.
- Ferulic acid is a constituent of plant cell walls, and is a substance that is expected to be widely used as a raw material for pharmaceuticals, cosmetics, agrochemicals, food additives, feed additives, liquid crystals, and so on.
- 3-methoxy-4-ethoxybenzenes their production method is being studied.
- Ferulic acid is known to be obtained by the condensation reaction of vanillin and malonic acid (J. Am. Chem. Soc, vol. 74, p. 5346, 1952). is not.
- the present inventors have isolated the eugenol-utilizing bacterium Pseudomonas florescens E118 (FERMBP-64997) from nature, and the cells were efficiently isolated. It was often found that eugenol was converted to ferulic acid (see Japanese Patent Application Laid-Open No. Hei 9-154591).
- the present invention has been made from the above viewpoint, and is expected to be widely used as a raw material for pharmaceuticals, cosmetics, agricultural chemicals, food additives, feed additives, liquid crystals, etc.
- 1-substitution — 3 It is an object of the present invention to provide a method for efficiently producing 4-methoxybenzene inexpensively and in large quantities.
- the present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, by culturing a specific microorganism in a medium containing clove oil itself, which is a natural product and inexpensive and easily available, 1-substitution is achieved.
- the inventors have found that it is possible to efficiently produce 1-3-methoxy-4-ethoxybenzenes, and have completed the present invention.
- the present invention is as follows.
- a microorganism belonging to the genus Pseudomonas which is capable of producing 1-substituted 13-methoxy-14-hydroxybenzenes from clove oil, is cultured in a medium containing clove oil.
- Monosubstituted 3- 3-methoxy 4-monobenzenes A method for producing 1-substituted-3-methoxy-14-methoxybenzenes, which is characterized by sampling.
- the clove oil used in the present invention can be used without particular limitation as long as it is generally used as clove oil.
- mono-substituted 1-3-methoxy-4-oxybenzenes to which the production method of the present invention is applied include ferulic acid, ferulaldehyde, coniferyl alcohol , Coniferyl aldehyde, diphosphorus, vanillic acid, vanillyl alcohol, etc., and also includes mixtures thereof.
- a microorganism belonging to the genus Pseudomonas belonging to the genus Pseudomonas which is capable of producing 1-substituted 1-3-methoxy-4-methoxybenzenes from clove oil belonging to the genus Pseudomonas, is used as a microorganism.
- Any microorganism can be used as long as it is a microorganism having the ability to convert to methoxybenzenes.
- Pseudomonas fluorescens having the above-mentioned ability is more preferably used, and particularly preferably, Pseudomonas fluorescens having the above-mentioned high conversion ability is used.
- the fluorescens E118 strain is used.
- Pseudomonas fluorescens E118 strain is a strain isolated by the present inventors, and was established on September 14, 1995 by the Ministry of International Trade and Industry, (Postal code: 3 05—8 5 6 6 1-3-1, Tsukuba-Higashi, Ibaraki, Japan) Deposited as microbial accession number FERMP—15 1885, September 10, 1998 It has been transferred to the International Deposit under the Budapest Treaty and deposited under the accession number FERMBP—6497.
- mutants obtained from these microorganisms by natural mutation, mutation treatment with ultraviolet irradiation or a mutagen can also be used.
- Mutation treatment includes ultraviolet irradiation, X-ray irradiation, radiation irradiation, treatment with mutagenic agents such as N-methyl-N, 12-nitronitrosoguanidine (NTG), artificial mutation treatment such as gene recombination, cell fusion, etc. What is necessary is just to carry out using the well-known method used per se.
- a medium containing clove oil may be used for culturing a microorganism belonging to the genus Pseudomonas and having the ability to produce 1-substituted-3-methoxy-4-methoxybenzenes from clove oil.
- Culture is usually performed aerobically.
- any medium containing clove oil and capable of growing the above-mentioned microorganism can be used.
- the clove oil contained in the medium is as described above.
- Medium components other than clove oil are appropriately selected according to the type of microorganism used.
- a medium component other than clove oil in a medium for growing microorganisms belonging to the genus Pseudomonas specifically, carbon sources such as maltose, lactose, fructose, and sucrose, meat dex, sodium glutamate, and peptone , Nitrogen sources such as yeast extract, various phosphates, Examples include inorganic salts such as metal salts such as sulfate, magnesium, calcium, boron, copper, potassium, iron, manganese, and sodium, and other organic trace components.
- components other than clove oil include, specifically, potassium phosphate buffer, physiological saline and the like.
- the medium may further contain a surfactant or a water-insoluble organic solvent.
- reaction in this specification, if necessary.
- culture solution in this specification, if necessary.
- the cultivation of the microorganisms for producing 1-substituted 1-3-methoxy-4-oxybenzenes from clove oil may be carried out using either a growing cell of the microorganism or a quiescent cell.
- resting cells are used.
- the resting cells of the microorganism used in the present invention are generally obtained, for example, by culturing the proliferating cells by the following method. In other words, by culturing the proliferating cells, it is possible to simultaneously produce resting cells and 1-substituted-3-methoxy-4-oxybenzenes from clove oil.
- a liquid medium for cultivation of the proliferating cells, a liquid medium is usually used in which the above-mentioned medium components and a suitable solvent such as water are mixed at an appropriate ratio depending on the microorganism used.
- a preferred liquid medium is 0.1 to 0.5% (v / v) of clove oil and 0.5 to 0.5% of sucrose. 3% (w / v;), dipotassium hydrogen phosphate 0.1 to 0.4% (w / v), peptone 0.05 to 0.2% (w / v), magnesium sulfate heptahydrate 0.
- the above metal salt mixed solution contains 0.4 g of calcium chloride dihydrate, 0.3 g of boric acid, 0.04 g of copper sulfate pentahydrate, and 0.1 g of potassium iodide in 1 L of deionized water.
- 0.2 g of ferrous sulfate heptahydrate, 0.4 g of manganese sulfate heptahydrate, 0.2 g of sodium molybdate dihydrate Is preferred.
- Culture conditions can be appropriately set according to the microorganism used.For example, preferable conditions when Pseudomonas fluorescens E118 strain is used are 18 to 72 hours at about 20 to 35 ° C. Culture conditions such as aeration and agitation culture can be mentioned. The above culture conditions can also be appropriately changed depending on the type of 1-substituted 1-3-methoxy-4-methoxybenzene to be produced. For example, in the above culture of Pseudomonas-fluorescens E118 strain, coniferyl alcohol or ferulic acid can be obtained if the culture time is as short as about 18 to 60 hours.
- vanillin or vanillic acid can be obtained in addition to ferulic acid.
- Resting cells of the microorganism are obtained by such cultivation, and mono-substituted 1-3-methoxy-4-oxybenzenes are produced and accumulated in the culture solution. Resting cells can be obtained from the culture solution by a conventional method such as centrifugation or filtration.
- usual purification methods such as passing the culture solution or supernatant after removal of the cells through an anion exchange resin column or a silylation gel column are used. Methods can be used.
- the reaction solution for the quiescent cell reaction may be of any composition as long as it contains quiescent cells, near-neutral buffer, and clove oil. Resting cells are usually suspended in physiological saline or an appropriate PH buffer and added to the reaction mixture in the form of a cell suspension. As the cell suspension, a suspension of quiescent cells suspended in an appropriate pH buffer solution by an ordinary method is used. Specifically, the quiescent cells obtained as described above are used.
- a suspension in a ratio of 0.1 to 0.8 g (wet weight) / 1 mL in physiological saline, 1 M potassium phosphate buffer (pH 7.0) or the like is used.
- the composition of the reaction solution is, for example, 30 to 70% (v / v) of the above cell suspension in deionized water or the like, 1 M phosphate buffer (PH 7.0) 5 to 20% (v / v;), clove oil 0.1 to 2%, and preferably 0.1 to 0.8% (w / v).
- the clove oil component When the clove oil component is completely consumed from the reaction solution during the reaction, it may be added to the reaction solution successively so that the above concentration is obtained.
- polyoxyethylene alkyl A surfactant such as telluric acid ester or a water-insoluble organic solvent such as n-heptane may be added to the reaction solution.
- the conditions of the quiescent cell reaction can be appropriately set according to the microorganism used.For example, preferable conditions when using Pseudomonas fluorescens E118 strain are 25 to 50 ° C.
- the reaction mixture containing resting cells, clove oil and pH buffer is allowed to stand for a period of time until the resting cells no longer consume clove oil components, preferably for 5 to 72 hours. , Shaking, or stirring. Thereafter, the reaction is stopped with a suitable reaction terminator such as methanol.
- the cells are removed by centrifugation or filtration, and the filtrate or supernatant obtained is subjected to a conventionally known method.
- a method of separating and purifying these by high performance liquid chromatography or the like may be employed.
- 1-substituted-3-methoxy-4-oxybenzenes may be separated and purified from the above supernatant or the like by crystallization.
- crystallization of ferulic acid is performed as follows. Hydrochloric acid is added dropwise to the supernatant to obtain ferulic acid crude crystals. Dissolve the crude crystals in a small amount of hot water and cool to obtain recrystallization. The recrystallization is repeated to obtain purified ferulic acid.
- the microorganisms can be used in the form of immobilized cells, which is preferable from the viewpoint of productivity.
- the microbial cells can be immobilized by any known method, as long as the enzyme system that converts clove oil in the cells into 1-substituted-1,3-methoxy-4-oxobenzenes is not inactivated. May be.
- the enzyme system that converts clove oil in the cells into 1-substituted-1,3-methoxy-4-oxobenzenes is not inactivated. May be.
- the above cells are adsorbed on a carrier such as ceramic or glass fine powder, the cells are cross-linked with a cross-linking agent such as glutaraldehyde, or the cells are wrapped with a polymer compound such as alginic acid.
- Proliferating cells may be used as the cells used for immobilization, but normally, quiescent cells are used.
- immobilized cells refer to immobilized resting cells.
- the reaction using the immobilized cells can be carried out by keeping the same temperature in a reaction solution having the same composition as the resting cells and shaking or stirring.
- the reaction time is also appropriately selected in the same manner as the quiescent cell reaction.
- the eluate may be collected by pouring the reaction solution into a column filled with immobilized cells. After stopping the reaction, fix it from the reaction solution by centrifugation or filtration. The supernatant is obtained by removing the transformed cells. From the supernatant, 1-substituted 3-methoxy-4-ethoxybenzenes such as ferulic acid are separated and purified by a known method. The separated immobilized cells can be used repeatedly.
- Example 1 Pseudomonas fluorescens El 18 (F ERM BP-6497) was added to clove oil 0.2% (v / v), sucrose 1% (w / v), hydrogen phosphate 0.2% (w / v), 0.3% (w / v), peptone 0.03% (w / v), magnesium sulphate heptahydrate 0.05% (w / v), yeast extract 0.03% (w / v) The mixture was cultured with aeration and agitation for 24 hours in 2 L of a culture solution containing 0.1% (v / v) of a mixture of v), and a metal salt and adjusted to pH 7.0.
- Example 2 The cells obtained by the culture in Example 1 were washed with physiological saline and suspended in physiological saline to obtain a cell suspension. The concentration of the obtained cell suspension was 0.5 g (wet weight) / mL.
- Example 3 The cells obtained by the culture of Example 1 were washed with physiological saline, and suspended in physiological saline to obtain a cell suspension. The concentration of the obtained cell suspension was 0.5 g (wet weight) / mL.
- the flow was developed at a flow rate of 1 minute, and the absorbance at 280 nm was detected.
- clove oil is a natural product, it is more suitable as a raw material due to the recent trend of consumers toward natural products. If it becomes possible to process 1-substituted 3-methoxy 4-hydroxybenzenes at the site of the cinnamon production area, 1-substituted 3-methoxy 4-one-year-old xybenzenes will become less expensive, and the locality of production will increase. It can be imagined to be useful for regional promotion.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
明細書 Specification
1—置換一 3 —メ トキシー 4一ォキシベンゼン類の製造法 技術分野 本発明は、 医薬品、 化粧品、 農薬、 食品添加物、 飼料添加物、 液晶などの原料 として広範な用途が期待されている 1—置換一 3—メ トキシ _ 4 _ォキシベンゼ ン類の製造法に関する。 景技術 Technical field The present invention is expected to be widely used as a raw material for pharmaceuticals, cosmetics, agricultural chemicals, food additives, feed additives, liquid crystals, etc. 1— The present invention relates to a process for producing substituted 3-methoxy-4-oxybenzenes. Landscape technology
1 一置換一 3—メ トキシ一 4—ォキシベンゼン類、 例えば、 フェルラ酸、 バニ リン、 バニリン酸等は、 天然に存在し、 天然物からの抽出により得ることができ るが、 天然物の保有量に限りがあり、 抽出の工程が面倒でコス トが高く、 大量生 産に向かない。 1 Monosubstituted 1-3-methoxy-4-methoxybenzenes, such as ferulic acid, vanillin, and vanillic acid, are naturally occurring and can be obtained by extraction from natural products, but the amount of natural products The extraction process is cumbersome and expensive, and is not suitable for mass production.
また、 化学的な合成法もあるが、 化学合成法は繁雑であり、 原料が高価で入手 困難である。 There is also a chemical synthesis method, but the chemical synthesis method is complicated and the raw materials are expensive and difficult to obtain.
フェルラ酸は植物の細胞壁の構成成分であり、 医薬品、 化粧品、 農薬、 食品添 加物、 飼料添加物、 液晶などの原料として広範な用途が期待されている物質であ るため、 1—置換一 3—メ トキシ一 4—ォキシベンゼン類の中でも、 特にその製 造法について検討されている。 Ferulic acid is a constituent of plant cell walls, and is a substance that is expected to be widely used as a raw material for pharmaceuticals, cosmetics, agrochemicals, food additives, feed additives, liquid crystals, and so on. Among the 3-methoxy-4-ethoxybenzenes, their production method is being studied.
フェルラ酸はバニリンとマロン酸の縮合反応によって得られることが知られて いるが(J . Am. Chem. Soc , 74卷, 5346頁, 1952年) 、 製造に 3週間ほどかかる ので工業的な方法ではない。 Ferulic acid is known to be obtained by the condensation reaction of vanillin and malonic acid (J. Am. Chem. Soc, vol. 74, p. 5346, 1952). is not.
近年、 米ヌ力廃油などをアル力リ加水分解することでフェルラ酸が得られてい るが (特公平 7 - 7 8 0 3 2号公報参照) 、 この方法でも依然として高価なので、 広範な用途の可能性が期待されつつその利用が妨げられている。 In recent years, ferulic acid has been obtained by hydrolyzing rice waste oil and the like (see Japanese Patent Publication No. 7-78032). However, even this method is still expensive, so it is widely used. Its use is being hindered while its potential is expected.
一方、 オイゲノールを微生物に作用させてバニリン関連物質を製造する試みが なされているが (特開平 5 - 2 2 7 9 8 0号公報、 特開平 3— 3 0 6 8 3号公報、 特開昭 6 2— 1 9 0 0 9 2号公報、 Agri c . Bi ol . Chem. , 41巻, 925- 929頁, 197 7年及び同誌 47卷, 2639- 2640頁, 1983年) 、 これらのいずれの方法もバニリンま たはバニリン酸をある程度効率的に製造できるものの十分に効率的な方法である とは言えない。 また、 フェルラ酸について言えば、 これらの方法は全く効率的な 製造法ではない。 On the other hand, attempts have been made to produce vanillin-related substances by allowing eugenol to act on microorganisms (Japanese Patent Application Laid-Open Nos. 5-228790, 3-306683, and 62-19092, Agric. Biol. Chem., 41, 925-929, 197 7 and 47, 2639-2640, 1983), all of these methods can produce vanillin or vanillic acid with some efficiency, but cannot be said to be sufficiently efficient. And for ferulic acid, these methods are not very efficient.
この様な状況から、 本発明者らは自然界よりオイゲノール資化性菌シュ一ドモ ナス . フルォレツセンス(Pseudomonas f luorescens ) E 1 1 8 ( F E R M B P - 6 4 9 7 ) を分離し、 この菌体が効率よくオイゲノールをフェルラ酸に変換す ることを見いだした (特開平 9— 1 5 4 5 9 1号公報参照) 。 Under such circumstances, the present inventors have isolated the eugenol-utilizing bacterium Pseudomonas florescens E118 (FERMBP-64997) from nature, and the cells were efficiently isolated. It was often found that eugenol was converted to ferulic acid (see Japanese Patent Application Laid-Open No. Hei 9-154591).
しかし、 上記方法に用いるオイゲノールを化学的な合成により製造するには、 グアヤコールァリルエーテルのオルト位を保護してクラィゼン転位を行えばよい が、 工程が複雑でコス トがかかる。 また、 天然物であり、 オイゲノール含量が高 い丁子油などの精油から精留ゃ抽出などの方法によりオイゲノールを単離するの も困難である。 However, in order to produce eugenol used in the above method by chemical synthesis, it is sufficient to protect the ortho position of guaiacol aryl ether and carry out Kreisen rearrangement, but the process is complicated and costly. Also, it is difficult to isolate eugenol from essential oils such as clove oil, which is a natural product and has a high eugenol content, by rectification and extraction.
そこで、 入手が容易な天然物を用いて安価で大量に 1—置換一 3—メ トキシ— 4 一ォキシベンゼン類を製造する方法の開発が望まれていた。 発明の開示 本発明は、 上記観点から為されたものであり、 医薬品、 化粧品、 農薬、 食品添 加物、 飼料添加物、 液晶などの原料として広範な用途が期待されている 1—置換 — 3—メ トキシ一 4—ォキシベンゼン類を、 安価で大量に、 つまり、 効率的に製 造する方法を提供することを課題とする。 Therefore, it has been desired to develop a method for producing 1-substituted-13-methoxy-4-methoxybenzenes inexpensively and in large quantities using readily available natural products. DISCLOSURE OF THE INVENTION The present invention has been made from the above viewpoint, and is expected to be widely used as a raw material for pharmaceuticals, cosmetics, agricultural chemicals, food additives, feed additives, liquid crystals, etc. 1-substitution — 3 It is an object of the present invention to provide a method for efficiently producing 4-methoxybenzene inexpensively and in large quantities.
本発明者らは、 上記課題を解決するために鋭意検討した結果、 天然物であり安 価で手に入りやすい丁子油そのものを含有する培地で、 特定の微生物を培養する ことで、 1—置換一 3—メ トキシー 4—ォキシベンゼン類を効率よく製造できる ことを見いだし、 本発明を完成するに至った。 The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, by culturing a specific microorganism in a medium containing clove oil itself, which is a natural product and inexpensive and easily available, 1-substitution is achieved. The inventors have found that it is possible to efficiently produce 1-3-methoxy-4-ethoxybenzenes, and have completed the present invention.
すなわち本発明は、 以下に示すものである。 That is, the present invention is as follows.
( 1 ) シュ一ドモナス属に属する、 丁子油から 1 _置換一 3 —メ トキシ一 4— ォキシベンゼン類を産生する能力を有する微生物を、 丁子油を含有する培地で培 養し、 培地中に 1 一置換一 3 —メ トキシー 4 一ォキシベンゼン類を生成蓄積せし め、 これを採取することを特徴とする、 1 _置換一 3—メ トキシ一 4—ォキシベ ンゼン類の製造法。 (1) A microorganism belonging to the genus Pseudomonas, which is capable of producing 1-substituted 13-methoxy-14-hydroxybenzenes from clove oil, is cultured in a medium containing clove oil. Monosubstituted 3- 3-methoxy 4-monobenzenes A method for producing 1-substituted-3-methoxy-14-methoxybenzenes, which is characterized by sampling.
( 2 ) シュ一ドモナス属に属する微生物が、 シユードモナス · フルォレツセン ス (Pseudomonas fluorescens) である ( 1 ) の 1一置換一 3—メ トキシ一 4—ォ キシベンゼン類の製造法。 (2) A method for producing 1-substituted 1-3-methoxy-14-oxybenzenes of (1), wherein the microorganism belonging to the genus Pseudomonas is Pseudomonas fluorescens.
(3 ) シュ一ドモナス · フルォレヅセンスが、 シユードモナス · フルォレッセ ンス E 1 1 8 (FERM BP— 6497 ) である ( 2) の 1 -置換一 3—メ ト キシ一 4一ォキシベンゼン類の製造法。 (3) A method for producing 1-substituted 1-3-methoxy-14-oxybenzenes according to (2), wherein the pseudomonas fluorescein is pseudomonas fluorescens E118 (FERM BP-6497).
(4 ) シユードモナス属に属する微生物として、 前記微生物の休止菌体を用い ることを特徴とする ( 1 ) の 1—置換一 3—メ トキシ一 4—ォキシベンゼン類の 製造法。 (4) The method for producing 1-substituted-13-methoxy-14-oxybenzenes according to (1), wherein resting cells of the microorganism belonging to the genus Pseudomonas are used.
( 5 ) シュ一ドモナス属に属する微生物を固定化菌体のかたちで用いることを 特徴とする ( 1 ) の 1一置換一 3—メ トキシ一 4—ォキシベンゼン類の製造法。 (5) The method for producing mono-substituted 1-3-methoxy-14-oxybenzenes according to (1), wherein a microorganism belonging to the genus Pseudomonas is used in the form of immobilized cells.
(6 ) 1—置換一 3—メ トキシ一 4—ォキシベンゼン類がコニフェリルアルコ ール、 バニリン、 およびバニリン酸から選ばれる一種以上の化合物である ( 1 ) の製造法。 以下、 本発明を詳細に説明する。 (6) The method for producing (1), wherein the 1-substituted 1-3-methoxy-14-oxybenzene is at least one compound selected from coniferyl alcohol, vanillin, and vanillic acid. Hereinafter, the present invention will be described in detail.
本発明で使用する丁子油としては、 一般に丁子油として用いられているもので あれば特に制限なく用いることができる。 具体的には、 インドネシア原産のフ ト モモ科常緑高木チヨウジ (Syzygium aromaticum Merrill et Perry (Eugenia ca ryophyllata Thunb.) ) のつぼみ、 花柄ないし葉を水又は水蒸気で抽出して得ら れる精油であれば、 抽出に用いられる部位に関係なく用いることができる。 本発 明においては、 丁子油として上記チヨウジの各部位から上記方法により精油を製 造して用いることもできるが、 丁子油は一般に市販されており容易に入手できる ので、 この様な市販品を用いることもできる。 また、 丁子油は天然物なので近年 の消費者の天然物指向の傾向から、 原料としてよりふさわしい。 The clove oil used in the present invention can be used without particular limitation as long as it is generally used as clove oil. Specifically, the essential oil obtained by extracting the buds, floral patterns or leaves of Syzygium aromaticum Merrill et Perry (Eugenia caryophyllata Thunb.) From Indonesia, which is native to Indonesia, with water or steam. It can be used regardless of the site used for extraction. In the present invention, it is possible to produce and use essential oil as clove oil by the above-mentioned method from each part of the cinnamon but the clove oil is generally commercially available and can be easily obtained. It can also be used. Since clove oil is a natural product, it is more suitable as a raw material due to the recent trend of consumers toward natural products.
本発明の製造方法が適用される 1一置換一 3—メ トキシー 4—ォキシベンゼン 類として、 具体的には、 フェルラ酸、 フェルラアルデヒ ド、 コニフェリルアルコ ール、 コニフェリルアルデヒ ド、 ノ^;二リン、 バニリ ン酸、 バニリルアルコールな どが挙げられ、 これらの混合物をも含むものである。 Specific examples of the mono-substituted 1-3-methoxy-4-oxybenzenes to which the production method of the present invention is applied include ferulic acid, ferulaldehyde, coniferyl alcohol , Coniferyl aldehyde, diphosphorus, vanillic acid, vanillyl alcohol, etc., and also includes mixtures thereof.
本発明の製造方法においては、 シユードモナス属に属する丁子油から 1 一置換 一 3—メ トキシー 4一ォキシベンゼン類を産生する能力を有する微生物として、 シユードモナス属に属し、 丁子油を 1—置換一 3—メ トキシ一 4 一ォキシベンゼ ン類に変換する能力を有する微生物であればいかなる微生物でも利用できるが、 上記能力を有するシユードモナス · フルォレヅセンスがより好ましく用いられ、 特に好ましくは上記変換能力の高いシュ一ドモナス · フルォレツセンス E 1 1 8 株が用いられる。 In the production method of the present invention, a microorganism belonging to the genus Pseudomonas belonging to the genus Pseudomonas, which is capable of producing 1-substituted 1-3-methoxy-4-methoxybenzenes from clove oil belonging to the genus Pseudomonas, is used as a microorganism. Any microorganism can be used as long as it is a microorganism having the ability to convert to methoxybenzenes. Pseudomonas fluorescens having the above-mentioned ability is more preferably used, and particularly preferably, Pseudomonas fluorescens having the above-mentioned high conversion ability is used. The fluorescens E118 strain is used.
なお、 シュ一ドモナス · フルォレッセンス E 1 1 8株は、 本発明者らが単離し た菌株であり、 平成 7年 9月 1 4日に通商産業省工業技術院生命工学工業技術研 究所 (郵便番号 3 0 5— 8 5 6 6日本国茨城県つくば巿東 1丁目 1番 3号) に微 生物受託番号 F E R M P— 1 5 1 8 5として寄託され、 平成 1 0年 9月 1 0日 にブダペス ト条約に基づく国際寄託に移管されて、 F E R M B P— 6 4 9 7の 受託番号で寄託されている。 In addition, Pseudomonas fluorescens E118 strain is a strain isolated by the present inventors, and was established on September 14, 1995 by the Ministry of International Trade and Industry, (Postal code: 3 05—8 5 6 6 1-3-1, Tsukuba-Higashi, Ibaraki, Japan) Deposited as microbial accession number FERMP—15 1885, September 10, 1998 It has been transferred to the International Deposit under the Budapest Treaty and deposited under the accession number FERMBP—6497.
また、 本発明には、 これらの微生物から、 自然変異や紫外線照射や変異剤によ る変異処理により得られる変異株も同様に使用することができる。 変異処理は、 紫外線照射、 X線照射、 放射線照射、 N—メチル—N,一二トローニトロソグァ二 ジン (N T G ) 等の変異誘起剤処理、 遺伝子組み替え、 細胞融合等の人為的変異 処理等のそれ自体既知の通常用いられる方法を用いて行えばよい。 In the present invention, mutants obtained from these microorganisms by natural mutation, mutation treatment with ultraviolet irradiation or a mutagen can also be used. Mutation treatment includes ultraviolet irradiation, X-ray irradiation, radiation irradiation, treatment with mutagenic agents such as N-methyl-N, 12-nitronitrosoguanidine (NTG), artificial mutation treatment such as gene recombination, cell fusion, etc. What is necessary is just to carry out using the well-known method used per se.
本発明において、 上記シユードモナス属に属する、 丁子油から 1—置換— 3— メ トキシー 4 一ォキシベンゼン類を産生する能力を有する微生物を培養するには、 丁子油を含有する培地を用いればよい。 培養は、 通常、 好気的に行われる。 前記 培地は、 丁子油を含有しかつ上記微生物が生育可能なものであればいかなるもの でも用いることができる。 培地に含まれる丁子油については、 上述の通りである。 丁子油以外の培地成分は、 使用する微生物の種類に応じて適宜選択される。 In the present invention, a medium containing clove oil may be used for culturing a microorganism belonging to the genus Pseudomonas and having the ability to produce 1-substituted-3-methoxy-4-methoxybenzenes from clove oil. Culture is usually performed aerobically. As the medium, any medium containing clove oil and capable of growing the above-mentioned microorganism can be used. The clove oil contained in the medium is as described above. Medium components other than clove oil are appropriately selected according to the type of microorganism used.
例えば、 シュ一ドモナス属に属する微生物の増殖用の培地における丁子油以外 の培地成分として具体的には、 麦芽糖、 乳糖、 果糖、 ショ糖等の炭素源、 肉ェキ ス、 グルタミン酸ナト リウム、 ペプトン、 酵母エキス等の窒素源、 各種リン酸塩、 硫酸塩、 マグネシウム、 カルシウム、 ホウ素、 銅、 カリウム、 鉄、 マンガン、 ナ トリゥム等の金属塩等の無機塩、 その他有機微量成分等を挙げることができる。 また、 同様に休止菌体反応においては、 丁子油以外の成分として、 具体的には、 リン酸カリウム緩衝液、 生理食塩水等が挙げられる。 この場合、 培地はさらに界 面活性剤や水不溶性有機溶媒を含有してもよい。 For example, as a medium component other than clove oil in a medium for growing microorganisms belonging to the genus Pseudomonas, specifically, carbon sources such as maltose, lactose, fructose, and sucrose, meat dex, sodium glutamate, and peptone , Nitrogen sources such as yeast extract, various phosphates, Examples include inorganic salts such as metal salts such as sulfate, magnesium, calcium, boron, copper, potassium, iron, manganese, and sodium, and other organic trace components. Similarly, in the resting bacterial cell reaction, components other than clove oil include, specifically, potassium phosphate buffer, physiological saline and the like. In this case, the medium may further contain a surfactant or a water-insoluble organic solvent.
なお、 増殖菌体 (増殖培養に用いる菌体) の培養と区別するために、 本明細書 においては必要に応じて、 休止菌体 (休止菌体反応に用いる菌体) の培養を 「反 応」 と呼び、 培養液を 「反応液」 と呼ぶこととする。 In addition, in order to distinguish it from the culture of the growing cells (cells used for growth culture), the culture of the quiescent cells (cells used for the quiescent cell reaction) is referred to as “reaction” in this specification, if necessary. And the culture solution is called the “reaction solution”.
本発明において、 丁子油から 1—置換一 3—メ トキシー 4—ォキシベンゼン類 を製造するために行う上記微生物の培養は、 微生物の増殖菌体、 休止菌体のどち らを用いて行ってもよいが、 好ましくは休止菌体が用いられる。 なお、 本発明に 用いられる微生物の休止菌体は、 一般的には、 例えば、 以下の方法によって増殖 菌体を培養することにより得られる。 つまり、 増殖菌体の培養によって、 休止菌 体の作製と、 丁子油からの 1—置換— 3—メ トキシ— 4—ォキシベンゼン類の製 造を同時に行うことができる。 In the present invention, the cultivation of the microorganisms for producing 1-substituted 1-3-methoxy-4-oxybenzenes from clove oil may be carried out using either a growing cell of the microorganism or a quiescent cell. However, preferably, resting cells are used. The resting cells of the microorganism used in the present invention are generally obtained, for example, by culturing the proliferating cells by the following method. In other words, by culturing the proliferating cells, it is possible to simultaneously produce resting cells and 1-substituted-3-methoxy-4-oxybenzenes from clove oil.
増殖菌体の培養には、 通常、 上記増殖用として挙げた培地成分と水等の適当な 溶媒を、 用いる微生物に応じて、 適当な割合で混合した液体培地が用いられる。 本発明において、 例えば、 シュ一ドモナス · フルォレツセンス E 1 1 8株を用い る場合には、 好ましい液体培地として、 丁子油 0. 1から 0. 5 % (v/v) 、 ショ糖 0. 5から 3 % (w/v;) 、 リン酸水素二カリウム 0. 1から 0. 4 % (w/v) , ペプトン 0. 05から 0. 2 % (w/v) , 硫酸マグネシゥム 7水 塩 0. 0 1から 0. 1 % (w/v) 、 、 酵母エキス 0. 1から 1 % (w/v) 及 び金属塩混液 0. 05から 0. 2 % (v/v) を含む液体培地で、 pHが 6. 5 から 8. 0のものを挙げることができる。 For cultivation of the proliferating cells, a liquid medium is usually used in which the above-mentioned medium components and a suitable solvent such as water are mixed at an appropriate ratio depending on the microorganism used. In the present invention, for example, when Pseudomonas fluorescens E118 strain is used, a preferred liquid medium is 0.1 to 0.5% (v / v) of clove oil and 0.5 to 0.5% of sucrose. 3% (w / v;), dipotassium hydrogen phosphate 0.1 to 0.4% (w / v), peptone 0.05 to 0.2% (w / v), magnesium sulfate heptahydrate 0. In a liquid medium containing 0.1 to 0.1% (w / v), yeast extract 0.1 to 1% (w / v), and a metal salt mixture 0.05 to 0.2% (v / v) And those having a pH of 6.5 to 8.0.
なお、 丁子油が培養中に消費され尽く した場合には、 好ましくは上記濃度とな るように、 これを逐次培地に添加してもよい。 また、 上記金属塩混液としては、 脱イオン水 1 L中に塩化カルシウム 2水塩 0. 4 g、 ホウ酸 0. 3 g、 硫酸銅 5 水塩 0. 04 g、 ヨウ化カリウム 0. 1 g、 硫酸第一鉄 7水塩 0. 2 g、 硫酸マ ンガン 7水塩 0. 4 g、 モリブデン酸ナトリウム 2水塩 0. 2 gを溶かした溶液 からなるものが好ましい。 When clove oil has been consumed during the culturing, it may be added to the medium successively so as to obtain the above-described concentration. In addition, the above metal salt mixed solution contains 0.4 g of calcium chloride dihydrate, 0.3 g of boric acid, 0.04 g of copper sulfate pentahydrate, and 0.1 g of potassium iodide in 1 L of deionized water. 0.2 g of ferrous sulfate heptahydrate, 0.4 g of manganese sulfate heptahydrate, 0.2 g of sodium molybdate dihydrate Is preferred.
培養条件は、 用いる微生物に応じて適宜設定することができるが、 例えば、 シ ユードモナス · フルォレツセンス E 1 1 8株を用いた場合の好ましい条件として、 約 20〜3 5°Cで 18〜7 2時間程度の通気撹拌培養等の培養条件が挙げられる。 また、 上記培養条件は、 製造しょうとする 1 _置換一 3—メ トキシー 4一ォキシ ベンゼン類の種類によっても適宜変更可能である。 例えば、 シュ一ドモナス - フ ルォレツセンス E 1 1 8株の上記培養においては、 培養時間が約 1 8〜60時間 と短いとコニフェリルアルコールまたはフェルラ酸が得られる。 培養時間が約 3 0〜 7 2時間と長いとフェルラ酸に加えてバニリンまたはバニリン酸が得られる。 この様な培養により微生物の休止菌体が得られ、 培養液中には 1一置換一 3— メ トキシ— 4—ォキシベンゼン類が生成蓄積される。 培養液より、 休止菌体を取 得するには遠心分離、 濾過等の常法によればよい。 また、 1 _置換一 3—メ トキ シ _ 4一ォキシベンゼン類の分離精製には、 上記菌体除去後の培養液や上清を陰 イオン交換樹脂カラム、 シリ力ゲルカラムに通す等の通常の精製方法を用いるこ とができる。 Culture conditions can be appropriately set according to the microorganism used.For example, preferable conditions when Pseudomonas fluorescens E118 strain is used are 18 to 72 hours at about 20 to 35 ° C. Culture conditions such as aeration and agitation culture can be mentioned. The above culture conditions can also be appropriately changed depending on the type of 1-substituted 1-3-methoxy-4-methoxybenzene to be produced. For example, in the above culture of Pseudomonas-fluorescens E118 strain, coniferyl alcohol or ferulic acid can be obtained if the culture time is as short as about 18 to 60 hours. If the culture time is as long as about 30 to 72 hours, vanillin or vanillic acid can be obtained in addition to ferulic acid. Resting cells of the microorganism are obtained by such cultivation, and mono-substituted 1-3-methoxy-4-oxybenzenes are produced and accumulated in the culture solution. Resting cells can be obtained from the culture solution by a conventional method such as centrifugation or filtration. In addition, for the separation and purification of 1-substituted 1-3-methoxy-4-monoxybenzenes, usual purification methods such as passing the culture solution or supernatant after removal of the cells through an anion exchange resin column or a silylation gel column are used. Methods can be used.
本発明においては、 上記の様にして得られる休止菌体を培養することにより、 さらに 1一置換一 3—メ トキシー 4一ォキシベンゼン類を製造することができる。 休止菌体反応のための反応液は、 休止菌体、 中性付近の緩衝液及び丁子油が含 まれるものであればいかなる組成のものでもよい。 休止菌体は、 通常、 生理食塩 水や適当な P H緩衝液に懸濁されて菌体懸濁液のかたちで反応液に添加される。 菌体懸濁液としては、 通常の方法で適当な p H緩衝液に休止菌体を懸濁させたも のが用いられるが、 具体的には、 上記の様にして得られる休止菌体を、 生理食塩 水、 1 Mリン酸カリウム緩衝液 (p H 7. 0 ) 等に、 0. 1〜0. 8 g (湿重量) / 1 mLの割合で懸濁したもの等が用いられる。 また、 反応液の組成としては、 例えば、 脱イオン水等に上記菌体懸濁液 3 0〜 7 0 % (v/v) 、 1 Mリン酸力 リゥム緩衝液 (PH 7. 0 ) 5〜 2 0 % (v/v;) 、 丁子油 0. 1〜 2 %、 好ま しくは 0. 1〜0. 8% (w/v) を加えた組成等が挙げられる。 反応中に丁子 油成分が反応液から消費され尽く した場合は、 好ましくは上記濃度となるように、 逐次反応液にこれを添加してもよい。 さらに、 ポリオキシエチレンアルキルェ一 テルリン酸エステル等の界面活性剤や n—へブタンなどの水不溶性有機溶媒を反 応液に添加してもよい。 In the present invention, by culturing the resting cells obtained as described above, it is possible to further produce monosubstituted 1-3-methoxy-4-hydroxybenzenes. The reaction solution for the quiescent cell reaction may be of any composition as long as it contains quiescent cells, near-neutral buffer, and clove oil. Resting cells are usually suspended in physiological saline or an appropriate PH buffer and added to the reaction mixture in the form of a cell suspension. As the cell suspension, a suspension of quiescent cells suspended in an appropriate pH buffer solution by an ordinary method is used. Specifically, the quiescent cells obtained as described above are used. A suspension in a ratio of 0.1 to 0.8 g (wet weight) / 1 mL in physiological saline, 1 M potassium phosphate buffer (pH 7.0) or the like is used. The composition of the reaction solution is, for example, 30 to 70% (v / v) of the above cell suspension in deionized water or the like, 1 M phosphate buffer (PH 7.0) 5 to 20% (v / v;), clove oil 0.1 to 2%, and preferably 0.1 to 0.8% (w / v). When the clove oil component is completely consumed from the reaction solution during the reaction, it may be added to the reaction solution successively so that the above concentration is obtained. In addition, polyoxyethylene alkyl A surfactant such as telluric acid ester or a water-insoluble organic solvent such as n-heptane may be added to the reaction solution.
休止菌体反応の条件は、 用いる微生物に応じて適宜設定することができるが、 例えば、 シュ一ドモナス · フルォレヅセンス E 1 1 8株を用いた場合の好ましい 条件として、 2 5 ~ 5 0 °Cの温度で、 休止菌体、 丁子油および p H緩衝液が入つ た反応液を、 前記休止菌体が丁子油成分をもはや消費しなくなるまでの時間、 好 ましくは 5から 7 2時間の間、 振盪、 あるいは撹拌して行う等の条件が挙げられ る。 その後、 メタノール等の適当な反応停止剤により反応を停止させる。 The conditions of the quiescent cell reaction can be appropriately set according to the microorganism used.For example, preferable conditions when using Pseudomonas fluorescens E118 strain are 25 to 50 ° C. At room temperature, the reaction mixture containing resting cells, clove oil and pH buffer is allowed to stand for a period of time until the resting cells no longer consume clove oil components, preferably for 5 to 72 hours. , Shaking, or stirring. Thereafter, the reaction is stopped with a suitable reaction terminator such as methanol.
反応液から生成蓄積した 1—置換— 3 —メ トキシ一 4 —ォキシベンゼン類を得 るには、 遠心分離または濾過にて菌体を除去し、 得られる濾液または上清から従 来公知の方法、 例えば、 高速液体クロマトグラフィー等にて、 これらを分離精製 する等の方法を採ればよい。 また、 上記上清等から結晶化により 1 —置換— 3— メ トキシー 4 _ォキシベンゼン類を分離精製してもよい。 例えば、 フェルラ酸の 結晶化は次の様にして行われる。 上清に塩酸を滴下してフェルラ酸の粗結晶を得 る。 粗結晶を少量の熱水に溶かし、 冷却して再結晶を得る。 再結晶を繰り返して 精製フェルラ酸を得る。 In order to obtain the 1-substituted-3-methoxy-14-oxybenzenes formed and accumulated from the reaction solution, the cells are removed by centrifugation or filtration, and the filtrate or supernatant obtained is subjected to a conventionally known method. For example, a method of separating and purifying these by high performance liquid chromatography or the like may be employed. Alternatively, 1-substituted-3-methoxy-4-oxybenzenes may be separated and purified from the above supernatant or the like by crystallization. For example, crystallization of ferulic acid is performed as follows. Hydrochloric acid is added dropwise to the supernatant to obtain ferulic acid crude crystals. Dissolve the crude crystals in a small amount of hot water and cool to obtain recrystallization. The recrystallization is repeated to obtain purified ferulic acid.
また、 本発明の製造方法においては、 上記微生物を固定化菌体のかたちで用い ることが可能であり、 生産性の上から好ましい。 Further, in the production method of the present invention, the microorganisms can be used in the form of immobilized cells, which is preferable from the viewpoint of productivity.
微生物菌体の固定化は、 菌体内の丁子油を 1—置換一 3—メ トキシ— 4—ォキ シベンゼン類に転換する酵素系が失活しない方法であれば、 従来公知のいかなる 方法で行われてもよい。 例えば、 上記菌体をセラミックやガラスの微粉末などの 担体に吸着させたり、 グルタルアルデヒド等の架橋剤で菌体同士を架橋させたり、 アルギン酸などの高分子化合物で菌体を包み込んだり してもよい。 固定化に用い る菌体として、 増殖菌体を用いてもよいが、 通常は、 休止菌体が用いられる。 以 下、 特に断りのない限り、 固定化菌体とは固定化休止菌体を意味する。 The microbial cells can be immobilized by any known method, as long as the enzyme system that converts clove oil in the cells into 1-substituted-1,3-methoxy-4-oxobenzenes is not inactivated. May be. For example, even if the above cells are adsorbed on a carrier such as ceramic or glass fine powder, the cells are cross-linked with a cross-linking agent such as glutaraldehyde, or the cells are wrapped with a polymer compound such as alginic acid. Good. Proliferating cells may be used as the cells used for immobilization, but normally, quiescent cells are used. Hereinafter, unless otherwise specified, immobilized cells refer to immobilized resting cells.
固定化菌体を用いた反応は、 休止菌体反応と同様な組成の反応液で同様に保温 し、 振盪あるいは攪拌して行うことができる。 反応時間も休止菌体反応と同様に して適宜選択される。 または、 固定化菌体を充填したカラムに反応液を流し込ん で溶出液を集めてもよい。 反応停止後、 遠心分離または濾過にて反応液から固定 化菌体を除去して上清を得る。 上清から公知の方法にて、 フェルラ酸等の 1—置 換一 3—メ トキシー 4—ォキシベンゼン類を分離精製する。 なお、 分離した固定 化菌体は反復使用できる。 発明を実施するための最良の形態 つぎに、 実施例により本発明を具体的に説明する。 本発明はこれらの実施例の みに限定されるものではない。 実施例 1 シュ一ドモナス · フルォレツセンス (Pseudomonas fluorescens) E l 1 8 ( F ERM BP— 6497) を、 丁子油 0. 2 % ( v/v) 、 ショ糖 1 % (w/v) 、 リン酸水素二力リウム 0. 2 % (w/v) 、 ペプトン 0. 0 3 % (w/v) 、 硫 酸マグネシウム 7水塩 0. 05 % (w/v) 、 酵母エキス 0. 03 % (w/v) 、 及び金属塩混合液 0. 1 % (v/v) からなり pHを 7. 0に調整した培養液 2 Lで 24時間通気撹拌培養した。 金属塩混合液として脱イオン水 1 Lに塩化カル シゥム 2水塩 0. 4 g、 ホウ酸 0. 3 g、 硫酸銅 5水塩 0. 04 g、 ヨウ化カリ ゥム 0. 1 g、 硫酸第一鉄 7水塩 0. 2 g、 硫酸マンガン 7水塩 0. 4 g、 モリ ブデン酸ナトリウム 2水塩 0. 2 gを溶解した溶液を用いた。 培養後の培養液を 遠心分離し、 上清を陰イオン交換樹脂 ( I RA) カラムに通し、 続いてシリカゲ ルカラムに通して精製フェルラ酸 0. 5 gおよびバニリン酸 0. l gを得た。 実施例 2 実施例 1の培養で得られた菌体を生理食塩水で洗浄し、 生理食塩水に懸濁し、 菌体懸濁液を得た。 得られた菌体懸濁液の濃度は 0. 5 g (湿重量) / mLであ つた。 The reaction using the immobilized cells can be carried out by keeping the same temperature in a reaction solution having the same composition as the resting cells and shaking or stirring. The reaction time is also appropriately selected in the same manner as the quiescent cell reaction. Alternatively, the eluate may be collected by pouring the reaction solution into a column filled with immobilized cells. After stopping the reaction, fix it from the reaction solution by centrifugation or filtration. The supernatant is obtained by removing the transformed cells. From the supernatant, 1-substituted 3-methoxy-4-ethoxybenzenes such as ferulic acid are separated and purified by a known method. The separated immobilized cells can be used repeatedly. BEST MODE FOR CARRYING OUT THE INVENTION Next, the present invention will be described specifically with reference to examples. The present invention is not limited to only these examples. Example 1 Pseudomonas fluorescens El 18 (F ERM BP-6497) was added to clove oil 0.2% (v / v), sucrose 1% (w / v), hydrogen phosphate 0.2% (w / v), 0.3% (w / v), peptone 0.03% (w / v), magnesium sulphate heptahydrate 0.05% (w / v), yeast extract 0.03% (w / v) The mixture was cultured with aeration and agitation for 24 hours in 2 L of a culture solution containing 0.1% (v / v) of a mixture of v), and a metal salt and adjusted to pH 7.0. 0.4 g of calcium chloride dihydrate in 1 L of deionized water as a metal salt mixture, 0.3 g of boric acid, 0.04 g of copper sulfate pentahydrate, 0.1 g of potassium iodide, sulfuric acid A solution prepared by dissolving 0.2 g of ferrous heptahydrate, 0.4 g of manganese sulfate heptahydrate, and 0.2 g of sodium molybdate dihydrate was used. The culture solution after the culture was centrifuged, and the supernatant was passed through an anion exchange resin (IRA) column, and then passed through a silica gel column to obtain 0.5 g of purified ferulic acid and 0.1 lg of vanillic acid. Example 2 The cells obtained by the culture in Example 1 were washed with physiological saline and suspended in physiological saline to obtain a cell suspension. The concentration of the obtained cell suspension was 0.5 g (wet weight) / mL.
この菌体懸濁液 1 mLに 1 Mリン酸カリウム緩衝液 (p H 7. 0) 0. 2 m L と丁子油 4 Omgを加え、 脱イオン水で 2 mLにした反応液を 3 0°Cで 4時間振 盪した。 To 1 mL of this cell suspension was added 0.2 mL of 1 M potassium phosphate buffer (pH 7.0) and 4 Omg of clove oil, and the reaction solution was made up to 2 mL with deionized water. Shake at C for 4 hours.
上記 4時間の振盪の後、 2 mLのメタノールを加えて反応を停止した。 その後、 反応液を遠心分離し、 分離した上清について高速液体クロマトグラフィ一でフエ ルラ酸等の 1—置換一 3—メ トキシ一 4—ォキシベンゼン類の分析を行った。 高速液体クロマトグラフィーは、 サイズが 4. 6 x 1 5 0 mmの OD S C 1 8カラムを用い、 メタノール :脱イオン水 :酢酸 = 45 : 5 2 : 3の成分比の溶 出液を毎分 1. 0 mLの流速で流して展開し、 280 nmの吸光度を検出した。 標準のフェルラ酸の保持時間である 3. 0分付近のピークをフェルラ酸、 2. 2 分付近のピークをバニリン酸とした。 After shaking for 4 hours, 2 mL of methanol was added to stop the reaction. afterwards, The reaction solution was centrifuged, and the separated supernatant was analyzed by high performance liquid chromatography for 1-substituted-13-methoxy-14-oxybenzenes such as ferulic acid. High-performance liquid chromatography uses an ODSC18 column with a size of 4.6 x 150 mm, and the eluate having a composition ratio of methanol: deionized water: acetic acid = 45: 52: 3 is converted to 1 per minute. The sample was developed at a flow rate of 0.0 mL, and the absorbance at 280 nm was detected. The peak around 3.0 minutes, which is the retention time of standard ferulic acid, was defined as ferulic acid, and the peak around 2.2 minutes was defined as vanillic acid.
その結果、 フェルラ酸 5 m gおよびバニリン酸 1. 5mgを得た。 実施例 3 実施例 1の培養で得られた菌体を生理食塩水で洗浄し、 生理食塩水に懸濁し、 菌体懸濁液を得た。 得られた菌体懸濁液の濃度は 0. 5 g (湿重量) /mLであ つた。 As a result, 5 mg of ferulic acid and 1.5 mg of vanillic acid were obtained. Example 3 The cells obtained by the culture of Example 1 were washed with physiological saline, and suspended in physiological saline to obtain a cell suspension. The concentration of the obtained cell suspension was 0.5 g (wet weight) / mL.
この菌体懸濁液 1 0 mLをセラミック微粉末 2 gに吸着させ、 これに 1 Mリン 酸カリウム緩衝液 (p H 7. 0) 2 mLと丁子油 0. 4 gを加え、 脱イオン水で 2 OmLにした反応液を 3 0°Cで振盪した。 24時間の振盪後、 丁子油をさらに 0. 4 g添加して振盪を続けた。 前記丁子油の再添加から 24時間の振盪後、 2 0 mLのメタノールを加えて反応を停止した。 その後、 反応液を遠心分離し、 分 離した上清について高速液体クロマトグラフィ一で 1—置換一 3—メ トキシ一 4 —ォキシベンゼン類を測定した。 10 mL of this cell suspension was adsorbed on 2 g of ceramic fine powder, and 2 mL of 1 M potassium phosphate buffer (pH 7.0) and 0.4 g of clove oil were added thereto. The reaction solution brought to 2 OmL with was shaken at 30 ° C. After shaking for 24 hours, an additional 0.4 g of clove oil was added and shaking was continued. After shaking for 24 hours after the re-addition of the clove oil, the reaction was stopped by adding 20 mL of methanol. Thereafter, the reaction solution was centrifuged, and the separated supernatant was subjected to high performance liquid chromatography to measure 1-substituted-13-methoxy-14-oxybenzenes.
高速液体クロマトグラフィーは、 サイズが 4. 6 1 5 0111111の003 C 1 8カラムを用い、 メタノール :脱イオン水 :酢酸 = 45 : 5 2 : 3の成分比の溶 出液を 1. 0 mL/分の流速で流して展開し、 280 nmの吸光度を検出した。 標準のフヱルラ酸の保持時間である 3. 0分付近のピークをフェルラ酸、 2. 2 分付近のピークをバニリン酸とした。 High-performance liquid chromatography uses a 003 C18 column with a size of 4.615111111, and the eluate having a component ratio of methanol: deionized water: acetic acid = 45: 52: 3 is 1.0 mL / The flow was developed at a flow rate of 1 minute, and the absorbance at 280 nm was detected. The peak around 3.0 minutes, which is the retention time of the standard ferulic acid, was ferulic acid, and the peak around 2.2 minutes was vanillic acid.
その結果、 フェルラ酸 1 1 0 m gおよびバニリン酸 3 3 m gを得た。 As a result, 110 mg of ferulic acid and 33 mg of vanillic acid were obtained.
上記と同じ操作を 1 0回繰り返し行ったが、 1回目の生産量に対する 1 0回目 のフェルラ酸の生産量の低下率は 1 2 %であった。 また、 1回目の生産量に対す る 1 0回目のバニリン酸の生産量の低下率は 1 5 %であった。 比較例 1 オイゲノールの化学合成 グアヤコール 1. 2 5 g、 Cu C 12 · H 20 0. 0 1 g、 塩化ナトリゥム飽和 水溶液 80 mLおよび塩化ァリル 0. 77 gを 5 0 0 mLフラスコに入れ、 攪拌 しながら 80°Cまで加熱した。 一時間後、 これに 1 0 % (W/V) 酢酸ナトリゥ ム水溶液 8. 2 mLを 3時間かけて加えた。 その後、 反応液を徐々に加熱して 1 00°Cになった後に空冷した。 室温になつてから トルエン 5 0 mLを加えて分層 させた。 トルェン層を塩化ナトリゥム飽和水溶液 5 0 mLで 3回洗浄した。 The same operation as above was repeated 10 times, but the rate of decrease of the ferulic acid production in the 10th production with respect to the first production was 12%. In addition, the rate of decrease in the production amount of vanillic acid in the 10th batch with respect to the first production volume was 15%. Chemical synthesis guaiacol 1. 2 5 g of Comparative Example 1 eugenol, placed Cu C 12 · H 2 0 0. 0 1 g, chloride Natoriumu saturated aqueous 80 mL and chloride Ariru 0. 77 g to 5 0 0 mL flask, stirred While heating to 80 ° C. One hour later, 8.2 mL of a 10% (W / V) aqueous sodium acetate solution was added thereto over 3 hours. Thereafter, the reaction solution was gradually heated to 100 ° C., and then air-cooled. After reaching room temperature, 50 mL of toluene was added thereto, and the layers were separated. The toluene layer was washed three times with 50 mL of a saturated aqueous solution of sodium chloride.
洗浄後のトルエン層から、 トルエンを蒸発させた後、 6mmH g (S I単位で は 80 0 P a) にて蒸留を行った。 1 1 5— 1 4 9 °Cでオイゲノール異性体含有 量 90 % (W/V) の留分 0. 42 mLが得られた。 このうち o—オイゲノール (天然型) は 1 1 % ( V/V) であり、 0. 5 gが得られた。 グアヤコールから 天然型オイゲノールへの収率は 8 %であった。 比較例 2 丁子油からのオイゲノールの精製 丁子油 3 00 gに、 5 % (w/w) の N a OH水溶液 1 0 0 mLを加え振盪し て他の油を除いた後、 希硫酸 1 00 mLを加えてオイゲノールを析出させた。 次 いで、 水 1 00 mLで 2回洗浄し、 無水硫酸マグネシウム 30 gを加えて乾燥さ せた。 次いで、 減圧蒸留により、 5 mmH gで 1 08°C〜 1 1 2°Cの留分を分留 することによりオイゲノール (純度 98 GC%) 3. 2 gを得た。 After the toluene was evaporated from the washed toluene layer, distillation was performed at 6 mmHg (800 Pa in SI unit). At 1 15—149 ° C., 0.42 mL of a fraction with a eugenol isomer content of 90% (W / V) was obtained. Of these, o-eugenol (natural type) was 11% (V / V), and 0.5 g was obtained. The yield from guaiacol to natural eugenol was 8%. Comparative Example 2 Purification of Eugenol from Clove Oil To 300 g of clove oil, 100 mL of a 5% (w / w) aqueous NaOH solution was added, and the mixture was shaken to remove other oils. Eugenol was precipitated by adding mL. Then, the mixture was washed twice with 100 mL of water, and dried by adding 30 g of anhydrous magnesium sulfate. Next, 3.2 g of eugenol (purity: 98 GC%) was obtained by fractionating a fraction at 108 ° C to 112 ° C at 5 mmHg by distillation under reduced pressure.
つまり、 丁子油からのォリゲノールの精製は収率約 1 %という非効率的なもの であった。 比較例 3 オイゲノールからのフェルラ酸の製造 シュ一ドモナス · フルォレツセンス E l 1 8 ( F E RM BP— 6497 ) を オイゲノール 0. 1 5 % (v/v) 、 ショ糖 1 % (w/v) , ペプトン 0. 1 % In other words, purification of origenol from clove oil was inefficient with a yield of about 1%. Comparative Example 3 Production of Ferulic Acid from Eugenol Pseudomonas fluorescens El 18 (FERM BP-6497) was added to Eugenol 0.15% (v / v), sucrose 1% (w / v), peptone 0.1%
(w/v) 、 リン酸水素二カリウム 0. 2 % (w/v) 、 硫酸マグネシウム 7水 塩 0. 05 % (w/v) 、 酵母エキス 0. 0 3 % (w/v) 及び金属塩混合液 0.(w / v), dipotassium hydrogen phosphate 0.2% (w / v), magnesium sulfate heptahydrate 0.05% (w / v), yeast extract 0.03% (w / v) and metal Salt mixture 0.
1 % (v/v) からなる pHを 7. 0に調整した培養液 1 Lで 24時間、 通気撹 拌培養した。 金属塩混合液として脱イオン水 1 L中に塩化カルシウム 2水塩 0. 4 g、 ホウ酸 0. 3 g、 硫酸銅 5水塩 0. 0 4 g、 ヨウ化カリウム 0. 1 g、 硫 酸第一鉄 7水塩 0. 2 g、 硫酸マンガン 7水塩 0. 4 g モリブデン酸ナトリウ ム 2水塩 0. 2 gを溶かした溶液を用いた。 培養後の培養液を遠心分離して得た 菌体を生理食塩水で洗浄し、 生理食塩水に懸濁し、 菌体懸濁液を得た。 得られた 菌体懸濁液の濃度は 0. 5 g (湿重量) / mLであった。 Aerated with 1 L of a 1% (v / v) culture adjusted to pH 7.0 for 24 hours. The culture was stirred. Calcium chloride dihydrate 0.4 g, boric acid 0.3 g, copper sulfate pentahydrate 0.04 g, potassium iodide 0.1 g, sulfuric acid in 1 L of deionized water as a metal salt mixture A solution prepared by dissolving 0.2 g of ferrous heptahydrate and 0.4 g of manganese sulfate heptahydrate in 0.2 g of sodium molybdate dihydrate was used. The cells obtained by centrifuging the culture after the culture were washed with physiological saline and suspended in physiological saline to obtain a cell suspension. The concentration of the obtained cell suspension was 0.5 g (wet weight) / mL.
この菌体懸濁液 l mLに、 1 Mリン酸カリウム緩衝液 (p H 7. 0 ) 0. 2 m Lとオイゲノール 1 . 6 m gを添加し、 脱イオン水で 2 mLにした反応液を、 3 0 °Cで 2時間振盪した。 その後、 2 mLのメタノールをこの反応液に加えて反応 を停止した後、 遠心分離して菌体を除去し、 分離した上清について、 高速液体ク 口マトグラフィ一でフェルラ酸の定量分析を行った。 標準のフヱルラ酸の保持時 間である 3. 0分付近のピークをフェルラ酸とし、 1 · 8 m gのフェルラ酸が検 出された。 しかし、 バニリン酸の保持時間である 2. 2分付近のピークは認めら れなかった。 産業上の利用性 本発明の方法を用いることにより、 医薬品、 化粧品、 農薬、 食品添加物、 飼料 添加物、 液晶などの原料として広範な用途が期待されている 1 一置換一 3—メ ト キシ _ 4—ォキシベンゼン類を安価で大量に製造することが可能となる。 To 1 mL of this cell suspension, 0.2 mL of 1 M potassium phosphate buffer (pH 7.0) and 1.6 mg of eugenol were added, and the reaction solution was made up to 2 mL with deionized water. The mixture was shaken at 30 ° C for 2 hours. Then, 2 mL of methanol was added to this reaction solution to stop the reaction, and the cells were removed by centrifugation.The separated supernatant was subjected to quantitative analysis of ferulic acid by high performance liquid chromatography. . The peak around 3.0 minutes, which is the retention time of the standard ferulic acid, was taken as ferulic acid, and 1.8 mg of ferulic acid was detected. However, no peak around 2.2 minutes, which is the retention time of vanillic acid, was observed. INDUSTRIAL APPLICABILITY By using the method of the present invention, mono-substituted 1-3-methoxy is expected to be widely used as a raw material for pharmaceuticals, cosmetics, agricultural chemicals, food additives, feed additives, liquid crystals, etc. _ 4- It will be possible to produce large quantities of 4-oxybenzene at low cost.
また、 丁子油は天然物なので近年の消費者の天然物指向の傾向から、 原料とし てよりふさわしい。 チヨウジ産地の現場で 1 —置換一 3—メ トキシー 4一ォキシ ベンゼン類にまで加工が可能になれば、 1—置換一 3—メ トキシー 4一才キシべ ンゼン類がより安価になり、 また産地の地域振興に役立つことが想像できる。 Since clove oil is a natural product, it is more suitable as a raw material due to the recent trend of consumers toward natural products. If it becomes possible to process 1-substituted 3-methoxy 4-hydroxybenzenes at the site of the cinnamon production area, 1-substituted 3-methoxy 4-one-year-old xybenzenes will become less expensive, and the locality of production will increase. It can be imagined to be useful for regional promotion.
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10/95514 | 1998-03-24 | ||
| JP9551498A JPH11266890A (en) | 1998-03-24 | 1998-03-24 | Production of 1-substituted-3-methoxy-4-oxybenzenes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1999049068A1 true WO1999049068A1 (en) | 1999-09-30 |
Family
ID=14139690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP1999/001493 Ceased WO1999049068A1 (en) | 1998-03-24 | 1999-03-24 | Process for producing 1-substituted-3-methoxy-4-oxybenzenes |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPH11266890A (en) |
| WO (1) | WO1999049068A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06153924A (en) * | 1992-08-17 | 1994-06-03 | Haarmann & Reimer Gmbh | Production of substituted methoxyphenol and microorganism suited for this purpose |
| JPH09154591A (en) * | 1995-12-05 | 1997-06-17 | Chisso Corp | Production of ferulic acid |
| WO1997031101A1 (en) * | 1996-02-23 | 1997-08-28 | Chisso Corporation | NOVEL OXIDOREDUCTASE AND PROCESSES FOR PRODUCING 3-(p-HYDROXYPHENYL)-2-PROPENOL DERIVATIVES AND OTHER COMPOUNDS USING THE SAME |
| JPH10155496A (en) * | 1996-11-29 | 1998-06-16 | Haarmann & Reimer Gmbh | Synthetase for producing coniferyl alcohol, coniferyl aldehyde, ferulic acid, vanillin and vanillic acid and use thereof |
-
1998
- 1998-03-24 JP JP9551498A patent/JPH11266890A/en active Pending
-
1999
- 1999-03-24 WO PCT/JP1999/001493 patent/WO1999049068A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06153924A (en) * | 1992-08-17 | 1994-06-03 | Haarmann & Reimer Gmbh | Production of substituted methoxyphenol and microorganism suited for this purpose |
| JPH09154591A (en) * | 1995-12-05 | 1997-06-17 | Chisso Corp | Production of ferulic acid |
| WO1997031101A1 (en) * | 1996-02-23 | 1997-08-28 | Chisso Corporation | NOVEL OXIDOREDUCTASE AND PROCESSES FOR PRODUCING 3-(p-HYDROXYPHENYL)-2-PROPENOL DERIVATIVES AND OTHER COMPOUNDS USING THE SAME |
| JPH10155496A (en) * | 1996-11-29 | 1998-06-16 | Haarmann & Reimer Gmbh | Synthetase for producing coniferyl alcohol, coniferyl aldehyde, ferulic acid, vanillin and vanillic acid and use thereof |
Non-Patent Citations (1)
| Title |
|---|
| RABENHORST J.: "PRODUCTION OF METHOXYPHENOL-TYPE NATURAL AROMA CHEMICALS BY BIOTRANSFORMATION OF EUGENOL WITH A NEW PSEUDOMONAS SP.", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, SPRINGER, DE, vol. 46., 1 January 1996 (1996-01-01), DE, pages 470 - 474., XP002919133, ISSN: 0175-7598, DOI: 10.1007/s002530050846 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11266890A (en) | 1999-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH05227980A (en) | Production of vanillin and its related compound by fermentation | |
| JPH0775589A (en) | Method for producing protocatechuic acid | |
| JPH09140388A (en) | Method for producing stereoisomers of inositol | |
| WO1999049068A1 (en) | Process for producing 1-substituted-3-methoxy-4-oxybenzenes | |
| JP2006528486A (en) | Candida tropicalis CJ-FID strain (KCTC10457BP) and xylitol production method using the same | |
| JPS61247396A (en) | Production of genisteine | |
| JP4405631B2 (en) | Method for purification of conjugated linoleic acid isomers | |
| JPS588714B2 (en) | Oil extraction method from oil sand | |
| JP4309969B2 (en) | Novel oxidoreductase and method for producing 3- (p-hydroxyphenyl) -2-propenol derivatives and the like using the same | |
| JP2563074B2 (en) | Process for producing natural β-phenethyl alcohol | |
| JP4262528B2 (en) | (-)-Method for producing Vivo-Quercitol | |
| JP2681131B2 (en) | Method for producing lactosucrose by microorganism | |
| JP3747640B2 (en) | Process for producing optically active 1,2-diol cyclic carbonate | |
| JPH07213295A (en) | Method for producing 4-hydroxy-2-methylbenzoic acid using microorganism | |
| JP2901458B2 (en) | Method for producing gentianose | |
| JP3030896B2 (en) | WB968 substance group and production method thereof | |
| JPS6244915B2 (en) | ||
| JPH05137590A (en) | Purification of lactosyl fructoside by microorganism | |
| JPH09154591A (en) | Production of ferulic acid | |
| JPS5953838B2 (en) | Method for producing β-hydroxyvaleric acid | |
| KR0178088B1 (en) | Microbiological Conversion of Phenol Derivatives Using Pseudomonas KRC-K1 Strains | |
| JPH0521558B2 (en) | ||
| JPS6338038B2 (en) | ||
| JPH0121760B2 (en) | ||
| JPH0553476B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): ID SG |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| 122 | Ep: pct application non-entry in european phase |